<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02716506</url>
  </required_header>
  <id_info>
    <org_study_id>Finpop 2015</org_study_id>
    <nct_id>NCT02716506</nct_id>
  </id_info>
  <brief_title>FINPOP 2015: Incidence, Methods, Complications and Quality of Life of Pelvic Organ Prolapse Operations in Finland 2015</brief_title>
  <official_title>Finnish Pelvic Organ Prolapse Surgery Survey 2015: Incidence, Methods, Complications and Effect on Quality of Life of Pelvic Organ Prolapse Operations in Finland in 2015</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Society for Gynecological Surgery in Finland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Society for Gynecological Surgery in Finland</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to investigate the safety and effectivity of pelvic organ prolapse
      (POP) surgery. In this multi center study the population consists of POP operations done in
      Finland year 2015.The study is prospective and validated questionnaires are used to measure
      the symptoms of POP and the quality of life before and six months after the operation.
      Methods and complications of surgery are reported by doctors in all 40 participant hospitals.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients awaiting for surgical procedure for a symptomatic pelvic organ prolapse (POP) are
      recruited for the study. The recruiting is done in 41 hospitals in Finland, at gynecological
      outpatient clinics. Participants are given information of the study and give a written
      approval to join the study. Participants are asked to fill in questionnaires, that measure
      the quality of life. Three validated questionnaires are used: Pelvic Floor Distress Inventory
      PFDI-20, Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire PISQ-12 and
      health-related quality of life instrument 15D. These questionnaires are sent to participants
      6 months, 2 and 5 years after the surgical treatment. The participants are also asked to
      report adverse effects related to the treatment and their satisfaction to the treatment.
      Information about the surgical procedure (i.e. type and duration of the procedure, blood
      loss, antibiotic and thrombosis prophylaxis) by the operating doctors. Both immediate and
      delayed treatment-related adverse effects are also reported by the doctors. Data is partly
      collected by questionnaires filled in internet. All the collected data is protected by high
      security and coded before analyses. Permission of protocol used in this study is given by the
      Ethical Committee of University of Eastern Finland and Finnish National Institute for Health
      and Welfare.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>January 2015</start_date>
  <completion_date type="Anticipated">January 2025</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>5 Years</target_duration>
  <primary_outcome>
    <measure>Quality of Life After the POP Surgery</measure>
    <time_frame>24 months after the surgery</time_frame>
    <description>Quality of life is measured by using 15 dimensional quality of health measurement instrument. Minimum value is 0 and maximum value is 1. Higher scores mean better outcome.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Symptoms Related to Pelvic Organ Prolapse</measure>
    <time_frame>24 months after the surgery</time_frame>
    <description>Condition-specific questionnaire Pelvic Floor Distress Inventory (PFDI-20) is used. Minimum value is 0 and maximum value is 300. Higher scores mean more bothersome symptoms.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">3515</enrollment>
  <condition>Pelvic Organ Prolapse</condition>
  <arm_group>
    <arm_group_label>Symptomatic POP</arm_group_label>
    <description>POP surgery in year 2015</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>POP surgery</intervention_name>
    <description>Any surgical procedure that is done to treat the symptomatic POP</description>
    <arm_group_label>Symptomatic POP</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Women with a symptomatic pelvic organ prolapse (POP) operated in year 2015 in Finland
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Symptomatic pelvic organ prolapse

          -  Mental and psychological ability to understand the study information and to give an
             approval

          -  Knowledge of Finnish or Swedish language

        Exclusion Criteria:

          -  Other than Finnish or Swedish language

          -  Psychological disability to understand the study information
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>120 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Päivi Härkki, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Finnish Society of Gynecological Surgery</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UEF</name>
      <address>
        <city>Kuopio</city>
        <state>Eastern Finland</state>
        <zip>70100</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>November 10, 2015</study_first_submitted>
  <study_first_submitted_qc>March 17, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 23, 2016</study_first_posted>
  <results_first_submitted>October 17, 2018</results_first_submitted>
  <results_first_submitted_qc>October 17, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">February 22, 2019</results_first_posted>
  <last_update_submitted>June 13, 2019</last_update_submitted>
  <last_update_submitted_qc>June 13, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 26, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Society for Gynecological Surgery in Finland</investigator_affiliation>
    <investigator_full_name>Nina Mattsson</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>POP surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prolapse</mesh_term>
    <mesh_term>Pelvic Organ Prolapse</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Symptomatic POP</title>
          <description>POP surgery in year 2015
POP surgery: Any surgical procedure that is done to treat the symptomatic POP</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="3515"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>6 Months</title>
              <participants_list>
                <participants group_id="P1" count="2528">Patients that completed the questionnaires six months after the operation.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>2 Years</title>
              <participants_list>
                <participants group_id="P1" count="2351">Patients that completed the questionnaires two years after the operation.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2351"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1164"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Symptomatic POP</title>
          <description>Patients that were operated for POP in 2015 in Finland and participated the study</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="3512"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="3512"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1764"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1748"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="3512"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="64.0" spread="10.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="3512"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3512"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Finland</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="3512"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3512"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Quality of Life After the POP Surgery</title>
        <description>Quality of life is measured by using 15 dimensional quality of health measurement instrument. Minimum value is 0 and maximum value is 1. Higher scores mean better outcome.</description>
        <time_frame>24 months after the surgery</time_frame>
        <population>Analysis of the patients who answered the 15-D questionnaire 24 months after the operation.</population>
        <group_list>
          <group group_id="O1">
            <title>Symptomatic POP</title>
            <description>POP surgery in year 2015
POP surgery: Any surgical procedure that is done to treat the symptomatic POP</description>
          </group>
        </group_list>
        <measure>
          <title>Quality of Life After the POP Surgery</title>
          <description>Quality of life is measured by using 15 dimensional quality of health measurement instrument. Minimum value is 0 and maximum value is 1. Higher scores mean better outcome.</description>
          <population>Analysis of the patients who answered the 15-D questionnaire 24 months after the operation.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2314"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.898" lower_limit="0.894" upper_limit="0.902"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Symptoms Related to Pelvic Organ Prolapse</title>
        <description>Condition-specific questionnaire Pelvic Floor Distress Inventory (PFDI-20) is used. Minimum value is 0 and maximum value is 300. Higher scores mean more bothersome symptoms.</description>
        <time_frame>24 months after the surgery</time_frame>
        <population>Change in PFDI-20 scores 24 months after the operation compared to the baseline scores.</population>
        <group_list>
          <group group_id="O1">
            <title>Symptomatic POP</title>
            <description>POP surgery in year 2015
POP surgery: Any surgical procedure that is done to treat the symptomatic POP</description>
          </group>
        </group_list>
        <measure>
          <title>Symptoms Related to Pelvic Organ Prolapse</title>
          <description>Condition-specific questionnaire Pelvic Floor Distress Inventory (PFDI-20) is used. Minimum value is 0 and maximum value is 300. Higher scores mean more bothersome symptoms.</description>
          <population>Change in PFDI-20 scores 24 months after the operation compared to the baseline scores.</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2342"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="49.24" spread="44.61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Symptomatic POP</title>
          <description>POP surgery in year 2015
POP surgery: Any surgical procedure that is done to treat the symptomatic POP</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3512"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="3512"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Serious adverse event (Clavidien dindo IV)</sub_title>
                <description>Clavidien dindo classification</description>
                <counts group_id="E1" events="15" subjects_affected="15" subjects_at_risk="3512"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_vocab>Calvidien dindo I-II</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="353" subjects_at_risk="3512"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Minor adverse events</sub_title>
                <description>Clavidien dindo I-III</description>
                <counts group_id="E1" events="353" subjects_affected="353" subjects_at_risk="3512"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr Nina Mattsson</name_or_title>
      <organization>Kanta-Häme Central Hospital</organization>
      <phone>+358407338307</phone>
      <email>nina.mattsson@fimnet.fi</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

